In line with this, receptor block also produced a significant reduction in both CLL and Th cell CD43 expression (Figure S5A), followed by a selective decrease in CLL galectin-1 expression (Figure S5B), which may account for the specific inhibition of proliferating CLL cells. Here, LGALS1 is linked to B-cell chronic lymphocytic leukemia.